Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EZETIMIBE\ROSUVASTATIN Cause Dizziness? 9 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Dizziness have been filed in association with EZETIMIBE\ROSUVASTATIN. This represents 2.7% of all adverse event reports for EZETIMIBE\ROSUVASTATIN.

9
Reports of Dizziness with EZETIMIBE\ROSUVASTATIN
2.7%
of all EZETIMIBE\ROSUVASTATIN reports
0
Deaths
1
Hospitalizations

How Dangerous Is Dizziness From EZETIMIBE\ROSUVASTATIN?

Of the 9 reports, 1 (11.1%) required hospitalization, and 1 (11.1%) were considered life-threatening.

Is Dizziness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\ROSUVASTATIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does EZETIMIBE\ROSUVASTATIN Cause?

Myalgia (58) Acute kidney injury (24) Arthralgia (17) Blood creatine phosphokinase increased (17) Leriche syndrome (16) Muscle spasms (16) Peripheral arterial occlusive disease (16) Asthenia (14) Drug abuse (14) Hepatic cytolysis (12)

What Other Drugs Cause Dizziness?

ADALIMUMAB (10,324) SACUBITRIL\VALSARTAN (8,548) TREPROSTINIL (7,405) DULOXETINE (6,983) LENALIDOMIDE (6,138) ETANERCEPT (5,928) METHOTREXATE (5,895) PREGABALIN (5,878) TERIPARATIDE (5,539) AMBRISENTAN (4,561)

Which EZETIMIBE\ROSUVASTATIN Alternatives Have Lower Dizziness Risk?

EZETIMIBE\ROSUVASTATIN vs EZETIMIBE\SIMVASTATIN EZETIMIBE\ROSUVASTATIN vs EZOGABINE EZETIMIBE\ROSUVASTATIN vs FACTOR XIII CONCENTRATE EZETIMIBE\ROSUVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI EZETIMIBE\ROSUVASTATIN vs FAMCICLOVIR

Related Pages

EZETIMIBE\ROSUVASTATIN Full Profile All Dizziness Reports All Drugs Causing Dizziness EZETIMIBE\ROSUVASTATIN Demographics